Eosinophil cationic protein and histamine after intestinal challenge in patients with cow's milk intolerance

Journal of Allergy and Clinical Immunology

Volumn 100, Issue 2, 1997, Pages 216-221

  Bengtsson, Ulf ^a   Knutson, Tina W ^b   Knutson, Lars ^b   Dannaeus, Anders ^b   Hällgren, Roger ^b   Ahlstedt, Staffan ^c,d  

^a SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

^b University Hospital

^c UNIVERSITY OF GOTHENBURG   (Sweden)

^d Thermo Fisher Scientific   (United States)

Author keywords

Albumin; Allergy; Eosinophil cationic protein; Eosinophils; Food intolerance; Gastrointestinal; Histamine; Mast cells

Indexed keywords

ANTIGEN RECOGNITION; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; COW; EOSINOPHIL; HISTAMINE RELEASE; HUMAN; MAST CELL; MILK INTOLERANCE; PRIORITY JOURNAL;

EID: 0030816710     PISSN: 00916749     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0091-6749(97)70227-6     Document Type: Article

References (40)

1. Svensson C, Andersson M, Persson CGA, Venge P, Alkner U, Pipkorn U. Albumin, bradykinins and eosinophil cationic protein on the nasal mucosal surface in patients with hay fever during natural allergen exposure. J Allergy Clin Immunol 1990;85:829-33.
2. Mehta H, Busse WW. Eosinophil as a therapeutic target in allergic disease. Compr Ther 1994;20:651-7.
3. Wardlaw AJ, Symon FS, Walsh GM. Eosinophil adhesion in allergic inflammation. J Allergy Clin Immunol 1994;94:1163-71.
4. Gleich GJ. The eosinophil and bronchial asthma: current understanding. J Allergy Clin Immunol 1990;85:422-36.
5. Metzger WJ, Richerson HB, Wasserman SI. Generation and partial characterization of eosinophil chemotactic activity and neutrophil chemotactic activity during early and late-phase asthmatic responses. J Allergy Clin Immunol 1986;72:282-90.
6. Durham SR. Allergic inflammation. Pediatr Allergy Immunol 1993;4(suppl 4):7-12.
7. Bignold LP. The eosinophil leucocyte: controversies of recruitment and function. Experientia 1995;51:317-27.
8. Kolmanskog S, Haneberg B. Immunoglobulin E in feces from children with allergy. Evidence of local production of IgE in the gut. Int Arch Allergy Appl Immunol 1985;76:133-7.
9. Raible DG, Schulman ES, DiMuzio J, Cardillo R, Post TJ. Mast cell mediators prostaglandin-D2 and histamine activate human eosinophils. J Immunol 1992;148:3536-42.
10. Vries JE. Atopic allergy and other hypersensitivities. Editorial overview. Curr Opin Immunol 1994;6:835-7.
11. Clark RAF, Gallin JI, Kapan AP. The selective eosinophil chemotactic activity of histamine. J Exp Med 1975;142:1462-7.
12. Moqbel R, MacDonald AJ, Kay AB. Enhanced granulocyte toxicity by mediators derived from anti-IgE-stimulated human leucocytes. Immunology 1986;59:87-92.
13. Brandtzaeg P. Bengtsson U, Halstensen TS, Hvatum M, Kett K, Rognum TO, et al. Mucosal immunology and food antigens. Nutritional aspects and developments. Bibl Nutr Dieta 1991;48:30-54.
14. Mensinga TT, Schouten JP, Rijcken B, Weiss ST, Van der Lende R. Host factors and environmental determinants associated with skin test reactivity and eosinophilia in a community-based population study. Ann Epiderniol 1994;4:382-92.
15. Knutson L, Odlind B, Hällgren R. A new technique for segmental jejunal perfusion in man. Am J Gastroenterol 1989;84:1278-84.
16. Venge P, Roxin L-E, Olsson I. Radioimmunoassay of human eosinophil cationic protein. Br J Haematol 1977;37:331-6.
17. Peterson CGB, Enander I, Nystrand J, Anderson AS, Nilsson L, Venge P. Radioimmunoassay of human eosinophil cationic protein (ECP) by an improved method. Establishment of normal levels in serum and turnover in vivo. Clin Exp Allergy 1991;121:561-7.
18. Hohman A, Labrooy J, Davidson GP, Shearman DJC. Measurement of specific antibodies in human intestinal aspirate: effect of the protease inhibitor phenylmethylsulfonyl fluoride. J Immunol Methods 1983;64:199-204.
19. Venge P, Dahl R, Fredens K, Hällgren R. Eosinophil cationic protein ECP and EPX in health and disease. In: Yoshida T, Torisu M, editors. Immunobiology of the eosinophil. New York: Elsevier; 1983. p. 163-77.
20. Saavedra-Delgado AM, Metcalfe DD. Interactions between food antigens and the immune system in the pathogenesis of gastrointestinal diseases. Ann Allergy 1985;55:694-702.
21. Smart HL, Mayberry JF. Atopy, food and ulcerative colitis. Hepatogastroenterology 1986;33:47-8.
22. Lavö B, Knutson L, Lööf L, Odlind B, Venge P, Hällgren R. Challenge with gliadin induces eosinophil and mast cell activation in the jejunum of patients with celiac disease. Am J Med 1989;87:655-60.
23. Bruijinzeel P, Storz E, van der Donk E, Bruijinzeel-Koomen C. Skin eosinophilia in patients with allergic asthma, patients with nonallergic asthma, and healthy controls. J Allergy Clin Immunol 1993:91:634-42.
24. Reed CE. The importance of eosinophils in the immunology of asthma and allergic disease. Ann Allergy 1994;72:376-80.
25. Coyle AT, Ackerman SJ, Burch R, Proud D, Irvin CG. Human eosinophil-granule major basic protein and synthetic polycations induce airway hyperresponsiveness in vivo dependent on bradykinin generation. J Clin Invest 1995;95:1735-40.
26. Weller PF. Roles of eosinophils in allergy. Curr Opin Immunol 1992;4:782-7.
27. Makino S, Fukuda T. Eosinophils and allergy in asthma. Allergy Proc 1995;16:13-21.
28. Juliusson S, Pipkorn U, Karlsson G, Enerbäck L. Mast cells and eosinophils in the allergic mucosal response to allergen challenge: changes in distribution and signs of activation in relation to symptoms. J Allergy Clin Immunol 1992;90:898-909.
29. Maluenda C, Phillips AD, Briddon A, Walker-Smith JA. Quantitative analysis of small intestinal mucosa in cow's milk-sensitive enteropathy. J Pediatr Gastroenterol Nutr 1984;3:349-55.
30. Winqvist I, Olson I, Werner S, Stenstam M. Variations of cationic proteins from eosinophil leukocytes in food intolerance and allergic rhinitis. Allergy 1981;36:419-23.
31. Hernäs J, Särnstrand B, Lindroth P, Peterson CGP, Venge P, Malmström A. Eosinophil cationic protein alters proteoglycan metabolism in human lung fibroblast cultures. Eur J Cell Biol 1992;59:352-63.
32. Lundgren JD, Davey RT Jr, Lundgren B, Mullol J, Marom Z, Logun C. et al. Eosinophil cationic protein stimulates and major basic protein inhibits airway mucus secretions. J Allergy Clin Immunol 1991;87:689-98.
33. Engström-Laurent A. Hällgren R. Circulating hyaluronate in rheumatoid arthritis: relationship to inflammatory activity and the effect of corticosteroid therapy. Ann Rheum Dis 1985;44:83-8.
34. Hällgren R, Venge P. Clinical impact of the monitoring of allergic inflammation. In: Mattson P. Ahlstedt S, Venge P, Thorell J, editors. The eosinophil in inflammation. London: Academic Press; 1991. p. 119-40.
35. Wasserman S. The lung mast cell: its physiology and potential relevance to defense of the lung. Environ Health Perspect 1980;35:153-64.
36. Goetzl EJ, Austen KF. Purification and synthesis of eosinophilotactic tetrapeptides of human lung tissue: identification as eosinophil chemotactic factor of anaphylaxis. Proc Natl Acad Sci USA 1975;72:4123-8.
37. 2 and histamine activate human eosinophils. J Immunol 1992;148:3336-42.
38. Bonini S, Tomassini M, Adriani E, Magrini L, Rumi C, Bussa S, et al. Markers of eosinophilic inflammation in allergic diseases. Allergy 1993;48:133-7.
39. Bachert C, Prohaska P, Pipkorn U. Ig-E positive mast cells on the human nasal mucosal surface in response to allergen exposure. Rhinology 1990;28:149-58.
40. Venge P. Soluble markers of allergic inflammation. Allergy 1994;49:1-8.